Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
10/2014
10/14/2014US8858915 Therapeutic or prophylactic agent, detection method and detection agent for metabolic syndrome, and method for screening of candidate compound for therapeutic agent for metabolic syndrome
10/09/2014WO2014165825A2 Therapeutic uses of genome editing with crispr/cas systems
10/09/2014WO2014165296A1 Methods and formulations to achieve tumor targeted double stranded rna mediated cell death
10/09/2014WO2014164805A1 Compositions and methods for targeting o-linked n-acetylglucosamine transferase and promoting wound healing
10/09/2014WO2014164753A1 Methods and compositions for managing vascular conditions
10/09/2014WO2014164703A1 Delivery of card protein as therapy for occular inflammation
10/09/2014WO2014164554A1 Chemotherapy-resistant immune cells
10/09/2014WO2014164442A1 Phytase
10/09/2014WO2014162962A1 Tumor antigen peptide
10/09/2014US20140302499 Pharmaceutical compositions and methods useful for modulating angiogenesis, inhibiting metastasis and tumor fibrosis, and assessing the malignancy of colon cancer tumors
10/09/2014US20140302171 Cysteine Peptide-Containing Health Drink
10/09/2014US20140301992 Compositions, methods and uses for treating solid tumors using lcmv-gp-vsv pseudotype vectors
10/08/2014EP2785359A1 Mesenchymal stromal cells and uses related thereto
10/07/2014US8853384 RNA interference mediating small RNA molecules
10/07/2014US8853382 Expression of antibody or a fragment thereof in lactobacillus
10/07/2014US8853178 Antisense modulation of PTP1B expression
10/07/2014US8853177 Use of inhibitors of toll-like receptors in the prevention and treatment of hypercholesterolemia and hyperlipidemia and diseases related thereto
10/07/2014US8853163 Methods for increasing vascular density and maintaining viability of microvascular endothelial cells using trk receptor ligands
10/07/2014US8852940 Embryonic stem cell specific microRNAs promote induced pluripotency
10/07/2014US8852939 Use of Vgll3 activity modulator for the modulation of adipogenesis
10/07/2014US8852860 Sperm-specific cation channel, CatSper1 and uses therefor
10/07/2014US8852612 Universal carrier for targeting molecules to Gb3 receptor expressing cells
10/07/2014US8852607 Excipients for use in adeno-associated virus pharmaceutical formulations, and pharmaceutical formulations made therewith
10/07/2014US8852602 Immunological herpes simplex virus antigens and methods for use thereof
10/07/2014US8852577 Recombinant proteins of Parapoxvirus ovis and pharmaceutical compositions therefrom
10/07/2014US8852576 Modified sodium iodide symporter proteins and uses thereof
10/07/2014US8852575 Cardiac muscle repair or regeneration using bone marrow-derived stem cells
10/07/2014US8852574 Cardiac muscle repair or regeneration using bone marrow-derived stem cells
10/07/2014US8852573 Cardiac muscle repair or regeneration using bone marrow-derived stem cells
10/07/2014US8852572 Cardiac muscle repair or regeneration using bone marrow-derived stem cells
10/07/2014US8852571 Cardiac muscle regeneration using mesenchymal stem cells
10/07/2014US8852570 Cardiac muscle regeneration using mesenchymal stem cells
10/07/2014US8852472 Coated lipid complexes and their use
10/02/2014WO2014160958A1 Compositions and methods for increasing the serum half-life of a therapeutic agent targeting complement c5
10/02/2014WO2014160871A2 Methods and agents for treating alzheimer's disease
10/02/2014WO2014160157A1 Immunoprotective primary mesenchymal stem cells and methods
10/02/2014WO2014160030A2 Compositions and methods for use of recombinant t cell receptors for direct recognition of tumor antigen
10/02/2014WO2014159775A1 Anti-clusterin monotherapy for cancer treatment
10/02/2014WO2014159631A1 Systems and methods for isolating nucleic acids
10/02/2014WO2014159546A1 Modified soluble vegf receptor-1 genes and vectors for gene therapy
10/02/2014WO2014159087A1 Radiolabeled anti-glypican-3 immunoconjugates for immuno-pet imaging of hepatocellular carcinoma
10/02/2014WO2014157965A1 Composition for treatment or metastasis suppression of cancers which includes p34 expression inhibitor or activity inhibitor as active ingredient
10/02/2014WO2014157429A1 Method for producing protein
10/02/2014WO2014157380A1 Therapeutic agent for wounds or fibrosis
10/02/2014WO2014154134A1 Polypeptide having inhibitory effect against infection by novel coronavirus hcov-emc 2012 and application of the polypeptide
10/02/2014US20140296326 Epidermal growth factor receptor (egfr) and methods of use in adenoviral-associated virus type 6 (aav6) transduction
10/02/2014US20140295543 Methods and compositions relating to polypeptides with rnase iii domains that mediate rna interference
10/02/2014US20140294940 Mrna therapy for urea cycle disorders
10/02/2014US20140294939 Pulmonary delivery of mrna
10/02/2014US20140294938 Mrna therapy for fabry disease
10/02/2014US20140294891 Microorganisms for therapy
10/02/2014US20140294842 Assays, Methods and Means
10/02/2014US20140294779 Modalities for the treatment of degenerative diseases of the retina
10/02/2014US20140294773 Modified cascade ribonucleoproteins and uses thereof
10/02/2014US20140294772 Thymidine kinase diagnostic assay for gene therapy applications
10/01/2014EP2783005A1 Recombinant serotype 5 (ac]5) adenoviral vectors
10/01/2014EP2782602A1 Method for prevention of colectomy
10/01/2014EP2782587A1 Stem cell-derived neural cells for cell therapy in neurological disorders
09/2014
09/30/2014USRE45170 Streptococcus suis vaccines and diagnostic tests
09/30/2014US8846895 Double-stranded RNA molecules with stability in mammalian body fluid, preparation and application thereof
09/30/2014US8846894 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
09/30/2014US8846893 Non-ionically bound constructs, and compositions and kits comprising domains
09/30/2014US8846889 Peptide biosynthesis and pain therapy
09/30/2014US8846859 Compositions and methods of use of targeting peptides against placenta and adipose tissues
09/30/2014US8846850 Amphiphilic macromolecules for nucleic acid delivery
09/30/2014US8846631 MicroRNA compositions and methods
09/30/2014US8846624 Modified protein polymers
09/30/2014US8846401 Promoters exhibiting endothelial cell specificity and methods of using same
09/30/2014US8846389 AAV4 vector and uses thereof
09/30/2014US8846385 Method and means for producing high titer, safe recombinant lentivirus vectors
09/30/2014US8846102 Non-viral compositions and methods for transfecting gut cells in vivo
09/30/2014US8846078 Brucellosis DNA vaccine
09/30/2014US8846030 Compounds and methods to enhance rAAV transduction
09/30/2014CA2506737C Methods and kits for diagnosing and treating b-cell chronic lymphocytic leukemia (b-cll)
09/25/2014WO2014153258A2 Improved thymidine kinase gene
09/25/2014WO2014153209A1 Antisense oligonucletotides for treatment of cancer stem cells
09/25/2014WO2014153205A1 Thymidine kinase diagnostic assay for gene therapy applications
09/25/2014WO2014153039A2 Tcf7l2 variant and methods of use thereof in diagnostic and drug screening assays
09/25/2014WO2014152940A1 Mrna therapeutic compositions and use to treat diseases and disorders
09/25/2014WO2014152932A1 Mirna for treating cancer and for use with adoptive immunotherapies
09/25/2014WO2014152646A1 Micrornas as functional mediators and biomarkers of bone metastasis
09/25/2014WO2014152622A1 Mirna biogenesis in exosomes for diagnosis and therapy
09/25/2014WO2014152540A1 Compositions and methods of altering cholesterol levels
09/25/2014WO2014152282A1 Allogeneic stromal vascular fraction transplantation by blood type matching
09/25/2014WO2014152122A2 Methods of altering vascular permeability and uses thereof
09/25/2014WO2014151687A2 Compositions and methods to treat aids
09/25/2014WO2014150835A1 Influenza nucleic acid molecules and vaccines made therefrom
09/25/2014WO2014148638A1 Aptamer to il-17 and use thereof
09/25/2014WO2014148529A1 Double-stranded nucleic acid molecule, dna, vector, cancer cell proliferation inhibitor, and pharmaceutical product
09/25/2014WO2014148216A1 Pharmaceutical composition for treatment of inflammatory bowel disease
09/25/2014WO2014147608A1 Magnetic inorganic iron-based nanoparticles
09/25/2014US20140287494 Mesendoderm and mesoderm cell populations
09/25/2014US20140287026 Process for preparing purified nucleic acid and the use thereof
09/25/2014US20140286930 Treatment of Mammalian Physiological Reaction of IgE Antibodies Present in Said Mammal Upon Contact with the Corresponding Antigen
09/25/2014US20140286905 Recombinant adenovirus comprising trans-splicing ribozyme and cancer-treating gene, and use thereof
09/25/2014US20140286864 Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy
09/24/2014EP2781599A1 Nucleic acid fragment binding to target protein
09/24/2014EP2781507A1 Cationic lipid having improved intracellular kinetics
09/23/2014US8841430 Use of regulatory sequences for specific, transient expression in neuronal determined cells
09/23/2014US8841271 Oligonucleotide complex compositions and methods of use as gene alteration tools
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 ... 870